Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Amicus Therapeutics Inc shares valued at $87,496 were sold by Campbell Bradley L on Apr 01 ’24. At $11.67 per share, Campbell Bradley L sold 7,500 shares. The insider’s holdings dropped to 886,654 shares worth approximately $9.95 million following the completion of this transaction.
Also, MCGLYNN MARGARET G sold 7,500 shares, netting a total of over 100,500 in proceeds. Following the sale of shares at $13.40 each, the insider now holds 59,289 shares.
Before that, MCGLYNN MARGARET G had sold 7,500 shares from its account. In a trade valued at $99,675, the Director traded Amicus Therapeutics Inc shares for $13.29 each. Upon closing the transaction, the insider’s holdings decreased to 7,500 shares, worth approximately $0.67 million.
As published in a research note from Morgan Stanley on December 19, 2023, Amicus Therapeutics Inc [FOLD] has been rated up from an Equal-weight to an Overweight and the price target has been revised to $20 from $15. Analysts at Morgan Stanley started covering the stock with ‘”an Equal-weight”‘ outlook in a report released in early September. Earlier on January 14, 2022, SVB Leerink upgraded its rating. Their new recommendation was “an Outperform” for FOLD stock which previously was a “a Mkt perform”.
Analyzing FOLD Stock Performance
During the last five days, there has been a drop of approximately -2.09%. Over the course of the year, Amicus Therapeutics Inc shares have dropped approximately -20.93%. Shares of the company reached a 52-week high of $14.53 on 01/02/24 and a 52-week low of $11.11 on 04/03/24. A 50-day SMA is recorded $12.46, while a 200-day SMA reached $12.31. Nevertheless, trading volume fell to 1.69 million shares from 2.08 million shares the previous day.
Support And Resistance Levels for Amicus Therapeutics Inc (FOLD)
According to the 24-hour chart, there is a support level at 11.11, which, if violated, would cause prices to drop to 11.00. In the upper region, resistance lies at 11.37. The next price resistance is at 11.52. RSI (Relative Strength Index) is 37.94 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.13, which suggests the price will decrease in the coming days. Percent R is at 86.59%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
Is Amicus Therapeutics Inc subject to short interest?
Stocks of Amicus Therapeutics Inc saw a sharp rise in short interest on Mar 15, 2024 jumping by 5.62 million shares to 32.4 million. Data from Yahoo Finance shows that the short interest on Feb 15, 2024 was 26.78 million shares. A jump of 17.35% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 8.3 of the overall float, the days-to-cover ratio (short ratio) jumped to 8.3.
